184 related articles for article (PubMed ID: 30282520)
1. Effect of once-only flexible sigmoidoscopy screening on the outcomes of subsequent faecal occult blood test screening.
Brown JP; Wooldrage K; Kralj-Hans I; Wright S; Cross AJ; Atkin WS
J Med Screen; 2019 Mar; 26(1):11-18. PubMed ID: 30282520
[TBL] [Abstract][Full Text] [Related]
2. High test positivity and low positive predictive value for colorectal cancer of continued faecal occult blood test screening after negative colonoscopy.
Brown JP; Wooldrage K; Wright S; Nickerson C; Cross AJ; Atkin WS
J Med Screen; 2018 Jun; 25(2):70-75. PubMed ID: 28467146
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
[TBL] [Abstract][Full Text] [Related]
4. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.
Hol L; van Leerdam ME; van Ballegooijen M; van Vuuren AJ; van Dekken H; Reijerink JC; van der Togt AC; Habbema JD; Kuipers EJ
Gut; 2010 Jan; 59(1):62-8. PubMed ID: 19671542
[TBL] [Abstract][Full Text] [Related]
5. Likely effect of adding flexible sigmoidoscopy to the English NHS Bowel Cancer Screening Programme: impact on colorectal cancer cases and deaths.
Geurts SM; Massat NJ; Duffy SW
Br J Cancer; 2015 Jun; 113(1):142-9. PubMed ID: 26110973
[TBL] [Abstract][Full Text] [Related]
6. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening.
Bretagne JF; Piette C; Cosson M; Durand G; Lièvre A
Dig Liver Dis; 2019 Oct; 51(10):1461-1469. PubMed ID: 31151896
[TBL] [Abstract][Full Text] [Related]
7. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
8. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy.
Sharp L; Tilson L; Whyte S; O'Ceilleachair A; Walsh C; Usher C; Tappenden P; Chilcott J; Staines A; Barry M; Comber H
Br J Cancer; 2012 Feb; 106(5):805-16. PubMed ID: 22343624
[TBL] [Abstract][Full Text] [Related]
10. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II.
Rasmussen M; Fenger C; Kronborg O
Scand J Gastroenterol; 2003 Jan; 38(1):114-8. PubMed ID: 12608473
[TBL] [Abstract][Full Text] [Related]
13. Negative screening colonoscopy after a positive guaiac faecal occult blood test: not a contraindication to continued screening.
Carrera A; McClements PL; Watling C; Libby G; Weller D; Brewster DH; Carey FA; Fraser CG; Steele RJ
Colorectal Dis; 2012 Aug; 14(8):943-6. PubMed ID: 21981347
[TBL] [Abstract][Full Text] [Related]
14. Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia-Brussels colorectal cancer screening programme.
Guo F; De Brabander I; Francart J; Candeur M; Polus M; Van Eycken L; Brenner H
Br J Cancer; 2020 Mar; 122(7):1109-1117. PubMed ID: 32066910
[TBL] [Abstract][Full Text] [Related]
15. Screening and primary prevention of colorectal cancer: a review of sex-specific and site-specific differences.
Massat NJ; Moss SM; Halloran SP; Duffy SW
J Med Screen; 2013; 20(3):125-48. PubMed ID: 24197771
[TBL] [Abstract][Full Text] [Related]
16. Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme.
Kearns B; Whyte S; Chilcott J; Patnick J
Br J Cancer; 2014 Oct; 111(9):1734-41. PubMed ID: 25180767
[TBL] [Abstract][Full Text] [Related]
17. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
[TBL] [Abstract][Full Text] [Related]
18. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test.
Denis B; Ruetsch M; Strentz P; Vogel JY; Guth F; Boyaval JM; Pagnon X; Ebelin JF; Gendre I; Perrin P
Gut; 2007 Nov; 56(11):1579-84. PubMed ID: 17616542
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
Murphy J; Halloran S; Gray A
BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
[TBL] [Abstract][Full Text] [Related]
20. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
